Article
What management for epidermal growth factor receptor-mutated non-small-cell lung cancer, with squamous cell transformation and T790M-acquired resistance mechanisms? A Case report and review of literature.
Anti-cancer drugs - 1 Jan 2022
Helissey Carole, Favre Loetitia, Nguyen Anh Tuan, Mamou Elodie, Lamboley Jean-Laurent
Abstract excerpt
Histological transformation into squamous cell carcinoma (SCC) is a rare mechanism of resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Its pathophysiology remains unclear and its management is particularly challenging. We report on tumor progression with SCC histological transformation associated with the T790M mutation in a patient with stage IV bronchial adenocarcinoma with an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
